Cite
HARVARD Citation
Grossmann, V. et al. (n.d.). CEBPA double‐mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76·8% of cases with TET2 and GATA2 alterations impacting prognosis. British journal of haematology. pp. 649-658. [Online].